Latest Videos |view all videos
Early Detection and Symptom Recognition Key for Young Adult Colorectal Cancer Patients
Rates of colorectal cancer are on the rise among young adults, a trend that continues to puzzle oncologists
“Nuance” is Important When Discussing Hormone Replacement Therapy
The use of hormone replacement therapy for women has become a controversial topic since the publication of the Women’s Health Initiative study more than 20 years ago
Roswell Park Set to Open Several New Trials this Year for Innovative CAR T-Cell Therapies
CAR T-cell therapies are the future of cancer treatment and Roswell Park Comprehensive Cancer Center is preparing to open a number of new trials based on research originating here and in partnership with the industry.
Experts from Roswell Park Comprehensive Cancer Center discuss genetic testing for mitigating and understanding the cancer risks of their patients.
Surgical Options for Treating Acromegaly
Acromegaly is a rare condition in which a tumor within the pituitary gland causes excessive release of growth hormones.
Roswell Park Accelerates CAR T-Cell Innovation with Upcoming Trials
Renier Brentjens, MD, PhD, has spent most of his career pioneering research into the development and use of CAR T-cell therapies in the hopes of finding innovative and effective treatments for cancer.
Two New CAR T-cell Therapy Trials Focus on Relapsed Multiple Myeloma
A pair of open and enrolling clinical trials are offering strong preliminary results for patients with relapsed multiple myeloma, says Ehsan Malek, MD, Director of Multiple Myeloma Translational Research at Roswell Park Comprehensive Cancer Center.
Sublobar Resection Surgery for Early Stage Non-Small Cell Lung Cancer Helps Preserve Lung Capacity
“For decades, the standard treatment for lung cancer was to remove the entire lobe of the lung that had the cancer in it,” says Mark Hennon, MD, FACS, Vice Chair of the Department of Thoracic Surgery at Roswell Park Comprehensive Cancer Center.
New CAR T Clinical Trials Underway at Roswell Park for Solid Tumor, Non-cancerous Diseases
While the focus and promise of CAR T-cell therapies has long been on liquid tumors and hematologic malignancies, new trials under way at Roswell Park Comprehensive Cancer Center are expanding the applications of immunotherapy to include other diseases.